Oslo, April 7 2014 - PCI Biotech announced that the company will be presenting at the 11th Annual BIO Asia International Conference. Hosted by the Biotechnology Industry Organization (BIO), the 11th Annual BIO Asia International Conference will take place April 8-9 in Tokyo, Japan.
About the BIO Asia International Conference
The 11th Annual BIO Asia International Conference is an exclusive, customized partnering forum that brings together U.S. and European drug development companies with Asian biotech and pharmaceutical companies interested in research collaborations and licensing agreements.
The presentation will be held April 8 local time 11:30 and the company will be represented by Mr. Gaël L'Hévéder, CBDO.
About PCI Biotech
PCI Biotech is a Norwegian biopharmaceutical company developing a novel light directed treatment system based on its patented photochemical internalisation (PCI) technology. Originating from world leading research at the Norwegian Radium Hospital, the PCI method involves first injecting the photosensitiser Amphinex® and thereafter the therapeutic drug to be specifically delivered to the diseased cells. When the diseased cells are illuminated the cells' endosomes are ruptured to allow successful intracellular delivery of the drug.
PCI can enhance the delivery of all molecules taken into the cell by endocytosis. This includes most types of macromolecules, drugs carried by antibodies or nanoparticles, as well as some small molecule drugs.
The PCI technology is also a versatile and innovative vaccination platform, which may specifically increase the cytotoxic T-cell response of vaccines. This is particularly important in therapeutic vaccination, when the immune system needs to recognise and destroy diseased cells (e.g. virus infected cells and cancer).
PCI Biotech follows a strategy to create value by improving the effect both of existing cancer drugs and by realizing the large potential in new therapeutics, including therapeutic vaccines.
For more information visit: www.pcibiotech.com
For further information, please contact
Ronny Skuggedal, CFO
rs@pcibiotech.no
Mobile: +47 9400 5757
PCI Biotech to present at 11th Annual BIO Asia International Conference
| Quelle: PCI Biotech Holding ASA
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.